Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems
Open accessThe DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
A major reason for the current reproducibility crisis in the life sciences is the poor implementation of quality control measures and reporting standards. Improvement is needed, especially regarding increasingly complex in vitro methods. Good Cell Culture Practice (GCCP) was an effort from 1996 to 2005 to develop such minimum quality standards also applicable in academia. This paper summarizes recent key developments in in vitro cell culture and addresses the issues resulting for GCCP, e.g. the development of induced pluripotent stem cells (iPSCs) and gene-edited cells. It further deals with human stem-cell-derived models and bioengineering of organo-typic cell cultures, including organoids, organ-on-chip and human-on-chip approaches. Commercial vendors and cell banks have made human primary cells more widely available over the last decade, increasing their use, but also requiring specific guidance as to GCCP. The characterization of cell culture systems including high-content imaging and high-throughput measurement technologies increasingly combined with more complex cell and tissue cultures represent a further challenge for GCCP. The increasing use of gene editing techniques to generate and modify in vitro culture models also requires discussion of its impact on GCCP. International (often varying) legislations and market forces originating from the commercialization of cell and tissue products and technologies are further impacting on the need for the use of GCCP. This report summarizes the recommendations of the second of two workshops, held in Germany in December 2015, aiming map the challenge and organize the process or developing a revised GCCP 2.0.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is now a range of genome- and epigenome-editing techniques (reviewed by Pamies et al., 2018), as well as regulation of gene expression by knock-out/in and RNA interference (RNAi) techniques or introduction of other genetic vectors.”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Pamies et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The concept of Good Cell Culture Practice (GCCP) (Coecke et al., 2005) was developed and gradually adapted to ongoing scientific progress (Pamies et al., 2018) as a guidance document for in vitro reporting standards.”
From In Vitro research Reproducibility: Keeping up High Standards (2019) · cites this paper as Pamies et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“GCCP 2.0 is trying to complement these for stem cell-derived models and microphysiological systems (MPS).”
From Toward good in vitro reporting standards (2019) · cites this paper as Pamies et al., 2018
The cited source says what the claim attributes to it.
In the citing paper
“Complementarily, Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as Pamies et al. 2018
The cited source says what the claim attributes to it.
In the citing paper
“This is particularly relevant in the study of monogenic diseases, for which the genes responsible for disease etiology are known (Pamies et al., 2018).”
From Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0) (2021) · cites this paper as Pamies et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Suspending OpenMP Tasks on Asynchronous Events: Extending the Taskwait Construct
Pereira, R., Martin, M., Roussel, A., Carribault, P., & Gautier, T. (2023) · Lecture Notes in Computer Science · doi:10.1007/978-3-031-40744-4_5 · Cited by 12,935
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Research works printed but not linked: 1
- altex1406111 · doi:10.14573/altex1406111 · Paper page
Cited by
Items 101–139 of 139
Neurotoxicology and Disease Modelling
Nunes, C., & Zurich, M. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-43939-2_12 · Cited by 4
PRICE, M., & Pistollato, F. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1753572 · Cited by 2
Scharkin, I., Dobner, J., Pierchala, N., Bartmann, K., Hübenthal, U., Bendt, F., Brockerhoff, G., Rossi, A., Fritsche, E., Tigges, J., et al. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103434 · Cited by 2
Anti-inflammatory Activity Methods
Lombardo, G. E., Maugeri, A., Russo, C., Musumeci, L., Cirmi, S., & Navarra, M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815123043123010005 · Cited by 2
Altuwayjiri, R. S., & Almami, I. S. (2025) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2025.13148 · Cited by 2
“25,26 29 This study compared NTERA-2 cL.D1 growth under two conditions and seeding densities to enhance understanding of their behavior.”
Assessing the fidelity of translation of non‐clinical assays: a Pharma perspective
Gintant, G. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15796 · Cited by 2
“This can lead to disparate conclusions regarding the translation and ultimate utility of the model (Pamies et al., 2018).”
BackgroundKrebs, A. (2019) · ALTEX · doi:10.14573/altex.1909271s · Cited by 19
Preciado-Gutiérrez, F. J., Masuoka‐Ito, D., Barrera-Bernal, J. L., del Campo-Téllez, B. I. M., Esparza‐Villalpando, V., & Ramírez-Orozco, R. E. (2023) · Revista Mexicana de Ciencias Pecuarias · doi:10.22319/rmcp.v14i2.6277 · Cited by 2
“Para evitar su contaminación, es común que se trabajen los cultivos celulares en un ambiente completamente estéril (6) .”
Spänle, J. V., Haiber, L. M., & Seeger, B. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1800157 · Cited by 1
“…bovine serum (FBS) in line with Good Cell Culture Practice (GCCP) recommendations (Coecke et al., 2005; Eskes et al., 2017; Pamies et al., 2017; Pamies et al., 2018; Tigges et al., 2021; Pamies et al., 2022), other animal-derived components remain prevalent and are often insufficiently…”
Allgemeine Aspekte der Primärkultur
Gstraunthaler, G. J. A., & Lindl, T. (2021) · Springer eBooks · doi:10.1007/978-3-662-62606-1_16 · Cited by 1
Boyd, S., Vahanan, M. M., Monroe, J., Conley, J. A., Carstens, K. E., & Shafer, T. J. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.103328 · Cited by 1
Identifying, naming and documenting of test and tool compound stocks
Leist, M. (2021) · ALTEX · doi:10.14573/altex.2012311 · Cited by 1
Ruarte, D. (2020) · Journal of Science Humanities and Arts - JOSHA · doi:10.17160/josha.7.5.706 · Cited by 1
“3 In concordance with the words Professor John Ioannidis, who said, “the replication has more value to discovery” and the principles on “Good Cell Culture Practice” (GCCP)(Pamies et al., 2018), our first steps are in order to validate the system.”
BackgroundThe effects of herbal extracts and compounds on the glucose metabolism in Hep G2 cells
Kandunuri, K. K. (2023) · London Met Repository (London Metropolitan University) · Cited by 8
Ramaswamy, S., Marusamy, K. O., & Gauthaman, K. (2019) · Springer eBooks · doi:10.1007/978-3-030-18375-2_8
What Do We Mean by Applied In Vitro Toxicology?
Gow, A. J., & Eskes, C. (2020) · Applied In Vitro Toxicology · doi:10.1089/aivt.2020.29023.ajg
Bussooa, A. (2020) · Nanotechnology Science and Applications · doi:10.2147/nsa.s266663
RetractedNovel approaches in predicting chemical toxicity using computational methods
Kisitu, J. (2020) · KOPS (University of Konstanz)
Documentation and Application of New Approach Methods in the Context of Regulatory Acceptance
Krebs, A. T. (2020) · KOPS (University of Konstanz)
Internship and Monograph reports entitled”Organ-on-a-chip: current status and future prospects"
Morais, A. S. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
de Leeuw, V. C. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/234
Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0)_suppl
Pamies, D. (2021) · ALTEX · doi:10.14573/altex.2111011s
Self-citationQualitätskontrolle und Cell Banking
Gstraunthaler, G. J. A., & Lindl, T. (2021) · Springer eBooks · doi:10.1007/978-3-662-62606-1_14
Chiriacò, M. S., Ferrara, F., & Primiceri, E. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3415-2
Chemical concentrations in cell culture compartments (C5) – free concentrations_suppl
Kisitu, J. (2020) · ALTEX · doi:10.14573/altex.2008251s
Standardisierung in der Zellkultur (Good Cell Culture Practice)
Gstraunthaler, G. J. A., & Lindl, T. (2021) · Springer eBooks · doi:10.1007/978-3-662-62606-1_15
Anuja, A. K., Rai, M. K., Gupta, L., Nigam, N., & Agarwal, V. (2024) · Indian Journal of Rheumatology · doi:10.1177/09733698241229949
“8,9 Therefore, primary chondrocyte cells reflect in vivo situation more truly and act as better models for pathophysiology studies as compared to the commercially available cell lines.”
BackgroundChalenko, M., Golembiovska, О., & Щетініна, В. (2025) · Біомедична інженерія і технологія · doi:10.20535/.2025.17.331625
Moyer, J. (2024) · DuEPublico (University of Duisburg-Essen) · doi:10.17185/duepublico/78195
Suhr, M., Lehmann, C., Bauer, C. R., Bender, T., Knopp, C. M., Freckmann, L., Öst Hansen, B., Henke, C., Aschenbrandt, G., Kühlborn, L. K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13467225
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G. J., Hewitt, P., Mow, T. J., Newham, P., Oinonen, T., Roth, A., et al. (2018) · The Novartis Repository (Novartis)
Picosecond InfraRed Laser-Mass Spectrometry for Rapid Detection of Skin Cancers
Katz, L. (2023) · TSpace (University of Toronto)
New insights in tumor-on-a-chip models for studying cancer drug resistance
Wang, Y., Shi, L., Li, J., Zhang, X., Ren, J., Jia, Q., Lv, L., Yang, L., Zhang, Z., Yang, J., et al. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156562
Advanced Techniques in Metal Neurotoxicity
Jimoh-Abdulghaffaar, H. O., Rabiu, S. O., & Amidu, S. B. (2026) · IGI Global eBooks · doi:10.4018/979-8-2600-1403-5.ch014
Finding a place for new approach methodologies (NAMs) in biomedical research
Schaffert, A., Ahluwalia, A. D., Bajramovic, J. J., Franco, N. H., Neuhaus, W., Olsson, I. A. S., & Sandvig, I. (2026) · Lab Animal · doi:10.1038/s41684-026-01806-6
Morais, A. S. A. S. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Metadata
- Authors
- Pamies, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Pamies, David
- ORCID
- Pamies, David
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2018
- Volume
- 35
- Issue
- 3
- Pages
- 353-378
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2799414163
- Cited by
- 127
- References
- 140
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 16 · 2021: 33 · 2020: 26 · 2019: 15 · 2018: 4
- FWCI
- 28.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- ALTEX (publishedVersion, cc-by)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- KOPS (University of Konstanz) (submittedVersion, cc-by)
- University of Twente Research Information (submittedVersion, other-oa)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Joint Research Centre (European Commission) (submittedVersion)
- University of Twente Research Information (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Funders
- Horizon 2020 Framework Programme (EU‐H2020, 681002)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- replication crisis, induced pluripotent stem cells, organoids, organ-on-a-chip, primary human cells, cell banks, high-content imaging, high-throughput measurement
- MeSH terms
- Animals, Animal Testing Alternatives, Education, Germany, Humans, Organoids, Quality Control, Guidelines as Topic, Cell Culture Techniques, Pluripotent Stem Cells, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



